A deep-pocketed syndicate--Orbimed Advisors, Clarus Ventures, TIAA-CREF and Goldman Sachs--supply $80 million to start Sientra, a seller of silicone breast implants and other aesthetics devices.
With all due respect to Sientra Inc. ’s actual investors, the $80 million Series B investment in the breast implant maker looks like a deal that in years past might have been found in the portfolio of Warburg Pincus. [See Deal]
Who else except Warburg Pincus would have been able to afford to put such significant capital behind the plans of Hani Zeini, a first time chief executive with extensive experience...
TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.
The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.
Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.
